HIPK3 expression level refers to prognosis and sensitivity to chemotherapy, higher HIPK3 expression with badly prognosis and chemoresistance in osteosarcoma and prostate cancer [8,26]. The gene discussed is HIPK3; the disease is prostate cancer.